Status epilepticus: Current concepts and management

Canadian Family Physician

Volumn 46, Issue SEPT, 2000, Pages 1817-1823

  Starreveld, Elout ^a   Starreveld, Anne A ^b  

^a GLENROSE REHABILITATION HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; DIAZEPAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL;

CLINICAL TRIAL; CONVULSION; DIFFERENTIAL DIAGNOSIS; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; ELECTROENCEPHALOGRAM; EMERGENCY TREATMENT; EPILEPSY; EPILEPTIC STATE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PROGNOSIS; RESPIRATION DEPRESSION; REVIEW; SEIZURE;

ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EMERGENCIES; FAMILY PRACTICE; HUMAN; INTENSIVE CARE; MONITORING, PHYSIOLOGIC; MORBIDITY; PRACTICE GUIDELINES; PROGNOSIS; STATUS EPILEPTICUS;

EID: 0033833335     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990;40(Suppl 2):9-13.
2. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-25.
3. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults and the elderly. Epilepsia 1992;33(Suppl 4):14.
4. Shorvon SD. The outcome of tonic clonic status epilepticus. Curr Opin Neurol 1994;7:93-5.
5. Legroscino G, Herdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997;38:1344-9.
6. Simon R, Pellock JN, DeLorenzo RJ. Acute morbidity and mortality of status epilepticus. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Vol 1. Philadelphia, Pa: Lippincott-Raven; 1998. p. 741-53.
7. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249(11):1452-4.
8. Treiman DM. Generalized convulsive status epilepticus. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Vol 1. Philadelphia, Pa: Lippincott-Raven; 1998. p. 669-80.
9. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
10. MacDonald RL, Kapur J. Acute cellular alterations in the hippocampus after status epilepticus. Epilepsia 1999;40 (Suppl 1):S9-20; discussion S21-2.
11. Lynch MW, Rutecki PA, Sutula TP. The effects of seizures on the brain. Curr Opin Neurol 1996;9(2):97-102.
12. 1 pyramidal neurons. Ann Neurol 1995;38:893-900.
13. Duncan JS, Shorvon SD, Fish DR. Emergency treatment: acute management of seizures, serial seizures and status epilepticus. In: Duncan JS, Shorvon SD, Fish DR, editors. Clinical epilepsy. New York, NY: Churchill Livingstone; 1995. p. 239-66.
14. Walker MC. The epidemiology and management of status epilepticus. Curr Opin Neurol 1998;11:149-54.
15. Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 1997;15(3):357-65.
16. Wallace SJ. Nasal benzodiazepines for management of acute childhood seizures? Lancet 1997;25(349):222.
17. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998;339(12):792-8.
18. O'Regan ME, Brown JK, Clarke M. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures? Dev Med Child Neurol 1996;38:1037-45.
19. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
20. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia 1999;40(Suppl 1):S3-8; discussion S21-2.
21. Maher J, McLachlan RS. Febrile convulsions maybe: is seizure duration the most important predictor of temporal lobe epilepsy? Brain 1995;118:1521-8.
22. Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 1994;44:1403-7.
23. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-6.
24. Leppik IE. Status epilepticus in the treatment of epilepsy: principles and practice. Philadelphia, Pa: Lee & Febiger; 1993. p. 678-85.
25. DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39(8):833-40.
26. Shorvon SD. Pseudostatus epilepticus. Lancet 1989;2(Aug 26):485.
27. Bateman DE. Pseudostatus epilepticus. Lancet 1989;2 (Nov 25):1278-9.
28. Meierkord H, Will DM, Fish D, Shorvon S. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology 1991;41:1643-6.
29. Kapur J. Status epilepticus in epileptogenesis. Curr Opin Neurol 1999;12(2):191-5.
30. Rice AC, Floyd CL, Lyeth BG, Hamm RJ, DeLorenzo RJ. Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. Epilepsia 1998;39:1148-57.
31. Browne TR. Pharmacologic principles in the management of status epilepticus. In: Merritt-Putnam lectures on status epilepticus [CME monograph]. Boston, Mass: American Epilepsy Society; 1996. p. 17-26.
32. Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 1978;23:874-80.
33. Spengler RF, Arrowsmith JB, Kilarski DJ, Buchanan C, Von Behren L, Graham DR. Severe soft tissue injury following intravenous infusion phenytoin. Arch Intern Med 1988;148:1329-33.
34. O'Brien TJ, Cascino GD, So EL, Hanna DR. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology 1998;51(4):1034-9.
35. Kendall JL, Reynolds M, Goldberg R. Intranasal midazolam in patients with status epilepticus. Ann Emerg Med 1997;29(3):415-7.